Announcements Trials
Browse Landscape

Phase

Phase 2 39Phase 1 18Phase 1/2 9Phase 3 7Phase EARLY_PHASE1 3Phase 2/3 2

Status

Completed 7Recruiting 5Active not recruiting 3Withdrawn 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Sarcoma 1Recurrence 1Neuroblastoma 1Glioma 1Desmoplastic Small Round Cell Tumor 1Brain Neoplasms 1

Interventions

pembrolizumab 8Nivolumab 7Magnetic Resonance Spectroscopy 7Radiotherapy 6Biopsy 4Temozolomide 3Specimen Handling 3Irinotecan 3Ipilimumab 3Fluorodeoxyglucose F18 3Dexamethasone 3Bevacizumab 3venetoclax 2niraparib 2gallium 68 PSMA-11 2durvalumab 2avelumab 2Tobacco Use Cessation Devices 2Standard of Care 2Rituximab 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Neoadjuvant Therapy 2Metastasectomy 2Immunoglobulin G 2FAPI-46 2Disulfides 2Cyclophosphamide 2Cetuximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × Temozolomide × Clear all
NCT05634707 2025-09-22

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Duke University

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
CNS

Brain Neoplasms, Glioma, Recurrence

NCT01189643 2025-09-05

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

NCT03189706 2025-07-02

Study of Chemoimmunotherapy for High-Risk Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
48 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡